bgg492
Showing 1 - 7 of 7
Partial Onset Seizures Trial in Worldwide (BGG492)
Completed
- Partial Onset Seizures
- BGG492
-
Tallahassee, Florida
- +15 more
Mar 2, 2021
Migraine Trial in Germany, Spain, United States (BGG492, Sumatriptan, Placebo)
Completed
- Migraine
- BGG492
- +2 more
-
Glendale, California
- +12 more
Dec 11, 2020
Muscle Spasticity Due to Multiple Sclerosis Trial (BGG492, Placebo)
Withdrawn
- Muscle Spasticity Due to Multiple Sclerosis
- BGG492
- Placebo
- (no location specified)
Apr 19, 2017
Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months
Withdrawn
- Patients With Migraine Equal of /More Than 3 and Equal of/ Less Than 12 Migraine Attacks/4 Weeks for Each of the Last 6 Months Preceding the Screening
- BGG492
- Placebo
- (no location specified)
Apr 19, 2017
Photosensitive Epilepsy Trial in Germany (BGG492, Placebo)
Completed
- Photosensitive Epilepsy
- BGG492
- Placebo
-
Bielefeld, Germany
- +3 more
Sep 21, 2016
Adrenocortical Adenoma, Endometrial Stromal Sarcomas Trial in Worldwide (MRI, CT or ultrasound was permitted if MRI was
Completed
- Adrenocortical Adenoma
- Endometrial Stromal Sarcomas
- MRI, CT or ultrasound was permitted if MRI was contraindicated
- +4 more
-
Tallahassee, Florida
- +19 more
Oct 24, 2016
Partial Onset Seizures Trial in Worldwide (BGG492, Placebo)
Withdrawn
- Partial Onset Seizures
- BGG492
- Placebo
-
Mobile, Alabama
- +22 more
Apr 30, 2012